These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3080855)

  • 21. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproate prevents the induction, but not the expression of morphine sensitization in mice.
    Li JX; Zhang Q; Liang JH
    Behav Brain Res; 2004 Jul; 152(2):251-7. PubMed ID: 15196792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH; Rosenbaum D; Chung EY
    Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644
    [No Abstract]   [Full Text] [Related]  

  • 26. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
    Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimyoclonic action of clonazepam: the role of serotonin.
    Chung Hwang E; Van Woert MH
    Eur J Pharmacol; 1979 Nov; 60(1):31-40. PubMed ID: 520416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [GABA-ergic component in the mechanism of action of the psychostimulant sidnocarb].
    Ganiev MM; Kharlamov AN; Shumkova OV
    Farmakol Toksikol; 1984; 47(3):30-5. PubMed ID: 6329817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin modifies the neuronal inhibitory responses to gamma-aminobutyric acid in the red nucleus: a microiontophoretic study in the rat.
    Licata F; Li Volsi G; Di Mauro M; Fretto G; Ciranna L; Santangelo F
    Exp Neurol; 2001 Jan; 167(1):95-107. PubMed ID: 11161597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals.
    Morland C; Nordengen K; Gundersen V
    Neurosci Lett; 2012 Oct; 527(2):100-4. PubMed ID: 22963924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats].
    Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS
    Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
    Smith CG; Bowery NG; Whitehead KJ
    Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of sodium valproate on the mediator amino acid content in the rat brain].
    Kharlamov AN; Kovalev GI; Shumkova OV
    Farmakol Toksikol; 1982; 45(5):31-4. PubMed ID: 6128253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of N-(2-propylpentanoyl)urea on hippocampal amino acid neurotransmitters in pilocarpine-induced seizure in rats.
    Khongsombat O; Watanabe H; Tantisira B; Patarapanich C; Tantisira MH
    Epilepsy Res; 2008 May; 79(2-3):151-7. PubMed ID: 18439803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of vigabatrin, a novel antiepileptic drug, on the anticonvulsant activity of conventional antiepileptics in pentetrazole-induced seizures in mice.
    Swiader M; Łuszczki J; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(3):363-70. PubMed ID: 14506315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of antimyoclonic drugs.
    Pranzatelli MR
    Clin Neurosci; 1995-1996; 3(4):246-52. PubMed ID: 8891398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
    Löscher W; Hörstermann D
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
    Löscher W
    CNS Drugs; 2002; 16(10):669-94. PubMed ID: 12269861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.
    Kerwin RW; Olpe HR; Schmutz M
    Br J Pharmacol; 1980; 71(2):545-51. PubMed ID: 6781578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.